Pain free IV

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Pain free IV
Generic name: LIDOCAINE
Manufacturer: Sambria Pharmaceuticals, LLC
Product type: HUMAN OTC DRUG
SPL set ID: 7aa4cb20-d452-417f-afdb-307df754ed75
SPL ID: 409245ac-ecd9-136a-e063-6394a90ab5e1
Version: 4
Effective date: 2025-10-07
Source export date: 2026-10-12
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:42:36

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Pain free IV	openfda.brand_name
generic name		LIDOCAINE	openfda.generic_name
manufacturer name		Sambria Pharmaceuticals, LLC	openfda.manufacturer_name
ndc	package	54723-008-01	openfda.package_ndc
ndc	product	54723-008	openfda.product_ndc
ndc11	package	54723000801	derived:openfda.package_ndc
rxcui		1421893	openfda.rxcui
spl id		409245ac-ecd9-136a-e063-6394a90ab5e1	id
spl set id		7aa4cb20-d452-417f-afdb-307df754ed75	set_id
unii		98PI200987	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Avoid contact with eyes. Do not use in large quantities, particularly over raw surface or blistered areas Stop use and ask doctor if Condition worsens or if symptons persists more than 7 days or clear up and occur again within a few days. Discontinue use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.